Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of basic and diluted earnings per share. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | | | | 2022 | | 2021 (1) | | 2020 (1) | Numerator: | | | | | | | | | | | Numerator for EPS - continuing operations | | | | | | | | | | | Net income (loss) | | | | | | $ | 290.5 | | | $ | (95.3) | | | $ | (573.8) | | Less: Income attributed to non-controlling interest | | | | | | 33.4 | | | 33.0 | | | 37.6 | | | | | | | | | | | | | | | | | | | | | | | | Numerator for basic and diluted EPS attributable to Delek | | | | | | $ | 257.1 | | | $ | (128.3) | | | $ | (611.4) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | Weighted average common shares outstanding (denominator for basic EPS) | | | | | | 70,789,458 | | | 73,984,104 | | | 73,598,389 | | | | | | | | | | | | | | | | | | | | | | | | Dilutive effect of stock-based awards | | | | | | 726,903 | | | — | | | — | | Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS) | | | | | | 71,516,361 | | | 73,984,104 | | | 73,598,389 | | | | | | | | | | | | | EPS: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Basic income (loss) per share | | | | | | $ | 3.63 | | | $ | (1.73) | | | $ | (8.31) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Diluted income (loss) income per share | | | | | | $ | 3.59 | | | $ | (1.73) | | | $ | (8.31) | | | | | | | | | | | | | The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be anti-dilutive: | | | | | | | | | | | Antidilutive stock-based compensation (because average share price is less than exercise price) | | | | | | 2,299,660 | | | 2,988,718 | | | 3,616,690 | | Antidilutive due to loss | | | | | | — | | | 598,775 | | | 466,254 | | Total antidilutive stock-based compensation | | | | | | 2,299,660 | | | 3,587,493 | | | 4,082,944 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) Adjusted to reflect the retrospective change in accounting policy from LIFO to FIFO for certain inventories. See Note 8 for further discussion.
|